Unknown

Dataset Information

0

GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer.


ABSTRACT: Whole exome sequencing (WES) recently identified frequent mutations in the genes of GPCR-mediated PI3K pathway (LPAR4, PIK3CA, and PTEN) in a Chinese population with papillary thyroid cancers (PTCs). The study found LPAR4 mutations as novel gene mutations in adult population with differentiated thyroid cancer (DTC). Here, we determine the prevalence of somatic mutations in this pathway (LPAR4 (exon 1), PIK3CA (exons 9 and 20) and PTEN (exons 5, 6, 7 and 8) in 323 thyroid samples consisting of 17 multinodular goiters (MNG), 89 pediatric DTCs, 204 adult DTCs, and 13 aggressive thyroid cancers including 10 poorly differentiated (PDTC) and 3 anaplastic thyroid cancer (ATC) from another ethnic population. We found 3.37% and 2.45% (includes Q214H, a novel PTEN mutation) in GPCR-mediated PI3K pathway of pediatric and adult DTCs, respectively. Analyses of 507 DTCs from thyroid Cancer Genome Atlas data (TCGA) revealed a low prevalence of mutations in this pathway (1.18%). In 13 cases with PDTC and ATC, we found no mutation in genes of this pathway. By contrast, analyses of 117 aggressive thyroid cancers (PDTC and ATC) from TCGA showed 13% of mutations in this pathway. Moreover, analyses of 1080 pan-cancer cell lines and 9020 solid tumors of TCGA data revealed high rates of mutations in this pathway (cell lines, 24.8%; tumors, 24.8%). In addition, PIK3CA + PTEN (p = <0.001) and LPAR4 + PIK3CA (p = 0.003) significantly co-occurred. Our study reveals a low prevalence of GPCR-mediated PI3K pathway mutations both in pediatric and adult DTCs corroborating the TCGA data and suggests a significant role of this pathway only in a small portion of DTCs. The high prevalence of mutations in this pathway in other solid malignancies suggests an important role in their pathogenesis making it an attractive target for therapeutic intervention both in a small subset of DTCs and other solid cancers.

SUBMITTER: Murugan AK 

PROVIDER: S-EPMC6609254 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer.

Murugan Avaniyapuram Kannan AK   Qasem Ebtesam E   Al-Hindi Hindi H   Alzahrani Ali S AS  

Oncotarget 20190625 41


Whole exome sequencing (WES) recently identified frequent mutations in the genes of GPCR-mediated PI3K pathway (<i>LPAR4</i>, <i>PIK3CA</i>, and <i>PTEN</i>) in a Chinese population with papillary thyroid cancers (PTCs). The study found <i>LPAR4</i> mutations as novel gene mutations in adult population with differentiated thyroid cancer (DTC). Here, we determine the prevalence of somatic mutations in this pathway (<i>LPAR4</i> (exon 1), <i>PIK3CA</i> (exons 9 and 20) and <i>PTEN</i> (exons 5, 6,  ...[more]

Similar Datasets

| S-EPMC5833015 | biostudies-literature
| S-EPMC10013413 | biostudies-literature
| S-EPMC4130654 | biostudies-literature
| S-EPMC4936197 | biostudies-literature
| S-EPMC6279666 | biostudies-literature
| S-EPMC4032892 | biostudies-literature
| S-EPMC6771006 | biostudies-literature
| S-EPMC4915222 | biostudies-literature
| S-EPMC4770767 | biostudies-literature
| S-EPMC3851544 | biostudies-literature